Alzheimer's disease treatment: Assessing caregiver preferences for mode of treatment delivery

被引:20
|
作者
Abetz, Linda [1 ]
Rofail, Diana [1 ]
Mertzanis, Polyxane [2 ]
Heelis, Rebecca [1 ]
Rosa, Kathleen [2 ]
Tellefsen, Crystal [2 ]
de Climens, Aude Roborel [3 ]
McBurney, Christopher [4 ]
Thomas, Simu [4 ]
机构
[1] Mapi Values, Adelphi Mill, Bollington SK10 5JB, Cheshire, England
[2] Mapi Values USA, Boston, MA USA
[3] Mapi Values Lyon, Lyon, France
[4] Novartis Pharmaceut, E Hanover, NJ USA
关键词
Alzheimer's disease; caregiver questionnaire; oral capsule; rivastigmine; transdermal patch; treatment preference; treatment satisfaction; QUALITY-OF-LIFE; RELEASE ORAL MORPHINE; TRANSDERMAL FENTANYL; CANCER PAIN; PATIENT ACCEPTABILITY; RIVASTIGMINE PATCH; SATISFACTION; ADHERENCE; EFFICACY; TOLERABILITY;
D O I
10.1007/s12325-009-0034-5
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Management of patients with Alzheimer's Disease (AD) can exert a substantial burden upon caregivers. As new modes of treatment administration are developed, it is important to assess caregiver satisfaction and preference in a standardized manner. This study describes the development of the Alzheimer's Disease Caregiver Preference Questionnaire (ADCPQ) to assess AD caregivers' satisfaction with and preference for patch or capsule treatments in AD patients. Twenty-five published articles (1987-2002) were reviewed to identify potential ADCPQ domains. Three caregiver focus groups (n=24) were conducted to develop a first draft of the questionnaire. After evaluating the acceptance of ADCPQ to caregivers through in-depth interviews (n=10), its psychometric properties were assessed using data from 986 patients enrolled in a multicenter, randomized, double-blind, four-arm, placebo- and active-controlled, 24-week trial. Focus groups indicated that caregivers expressed dissatisfaction with current AD treatment routines including limitations related to: efficacy, administration schedule, number of pills, adherence to treatment, side effects, and taking pills. In-depth interviews with caregivers found the ADCPQ to be comprehensible with an acceptable layout. The resultant ADCPQ comprises three modules: A) baseline, 11 items assessing treatment expectations; B) week 8, 33 items on satisfaction and preferences with treatment options; C) week 24, 10 items assessing overall opinions of treatment options. Missing data per item was low (a parts per thousand currency sign0.3%) and domain internal consistency reliability was good (0.71-0.91). Preference items were also valid when evaluating concordance and discordance between convenience and satisfaction patch and capsule domain scores. AD treatment puts a significant strain on caregivers. New modes of treatment delivery may be less burdensome to caregivers, thereby increasing satisfaction and potential treatment adherence. The ADCPQ was well accepted by AD caregivers and its domains demonstrated satisfactory psychometric properties. The ADCPQ is a useful tool to understand caregiver preferences for patch versus oral therapies in AD.
引用
收藏
页码:627 / 644
页数:18
相关论文
共 50 条
  • [1] Alzheimer’s disease treatment: Assessing caregiver preferences for mode of treatment delivery
    Linda Abetz
    Diana Rofail
    Polyxane Mertzanis
    Rebecca Heelis
    Kathleen Rosa
    Crystal Tellefsen
    Aude Roborel de Climens
    Christopher McBurney
    Simu Thomas
    Advances in Therapy, 2009, 26 : 627 - 644
  • [2] Defining the Role of the Caregiver in Alzheimer’s Disease Treatment
    Henry Brodaty
    Alisa Green
    Drugs & Aging, 2002, 19 : 891 - 898
  • [3] Defining the role of the caregiver in Alzheimer's disease treatment
    Brodaty, H
    Green, A
    DRUGS & AGING, 2002, 19 (12) : 891 - 898
  • [4] Transdermal delivery of treatment for Alzheimer's disease
    Chan, Agnes L. F.
    Chien, Yie W.
    Lin, Shun Jin
    DRUGS & AGING, 2008, 25 (09) : 761 - 775
  • [5] The effects of galantamine treatment on caregiver time in Alzheimer's disease
    Sano, M
    Wilcock, GK
    van Baelen, B
    Kavanagh, S
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2003, 18 (10) : 942 - 950
  • [6] Caregivers' preferences for the treatment of patients with Alzheimer's disease
    Karlawish, JHT
    Klocinski, JL
    Merz, J
    Clark, CM
    Asch, DA
    NEUROLOGY, 2000, 55 (07) : 1008 - 1014
  • [7] Impact of donepezil treatment for Alzheimer's disease on caregiver time
    Wimo, A
    Winblad, B
    Shah, SN
    Chin, W
    Zhang, R
    McRae, T
    CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (08) : 1221 - 1225
  • [8] Reduction of caregiver burden in Alzheimer's disease by treatment with galantamine
    Kaufer, DI
    Borson, S
    Kershaw, P
    Sadik, K
    CNS SPECTRUMS, 2005, 10 (06) : 481 - 488
  • [9] Caregiver preferences for pediatric asthma treatment delivery systems
    Hitchcock, William
    Mellon, Michael
    Memran, Marcos
    Parasuraman, Bhash
    Ramachandran, Sulabha
    Walzer, Stefan
    ADVANCES IN THERAPY, 2007, 24 (06) : 1240 - 1253
  • [10] Caregiver preferences for pediatric asthma treatment delivery systems
    William Hitchcock
    Michael Mellon
    Marcos Memran
    Bhash Parasuraman
    Sulabha Ramachandran
    Stefan Walzer
    Advances in Therapy, 2007, 24 : 1240 - 1253